Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.68461 | 73 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.51683 | 71 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.88375 | 74 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.38376 | 70 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.4069 | 71 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.80866 | 75 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.69215 | 73 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.47507 | 71 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.4169 | 70 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.39995 | 70 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.50497 | 71 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.53729 | 71 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.55152 | 72 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.50177 | 71 |